Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Pulmonary Hypertension Clinical Trials

102 recruiting trials for Pulmonary Hypertension. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
102
Total Trials
102
Recruiting Now
4
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT06573723

Institutional Registry of Rare Diseases

The goal of this observational study is to create a single macro registry system with data collection on common clinical features, grouping the different rare diseases (RD)....

Sponsor: Hospital Italiano de Buenos AiresEnrolling: 3801 location
RECRUITINGPhase 2NCT06570473

Feasibility Trial for a Right Ventricular Failure Platform Trial

The primary objective of the CRAVE feasibility trial is to assess the feasibility of conducting a larger CRAVE platform trial by performing a randomized trial of 30 participants...

Sponsor: University of AlbertaEnrolling: 305 locations
RECRUITINGNCT06526195

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of...

Sponsor: Abbott Medical DevicesEnrolling: 85020 locations
RECRUITINGPhase 2NCT03629340

Metformin for Pulmonary Hypertension HFpEF

The main objective of this study is to determine the clinical efficacy of metformin versus placebo and the therapeutic response with regards to functional capacity and...

Sponsor: University of California, San FranciscoEnrolling: 102 locations
RECRUITINGNCT06954727

China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization

Right heart catheterization(RHC) plays a crucial role in the diagnosis and treatment of pulmonary vascular diseases(PVD). In China, the lack of equipment and technical expertise...

Sponsor: China-Japan Friendship HospitalEnrolling: 100001 location
RECRUITINGNCT04654650

Prospective Registry and Biobank for Long-term Observational Studies in Adult Patients with Pulmonary Hypertension

Prospective registry and biobank for long-term observational studies in adult patients with pulmonary hypertension

Sponsor: Universitätsklinikum Hamburg-EppendorfEnrolling: 50001 location
RECRUITINGNCT06362382

Mobile Internet-based Remote Home Rehabilitation Improves Prognostic Function and Life Quality in Pulmonary Hypertension

The goal of this clinical trial is to learn the effectiveness of remote home-based exercise rehabilitation using mobile Internet technology for patients with pulmonary...

Sponsor: China-Japan Friendship HospitalEnrolling: 801 location
RECRUITINGPhase 3NCT07179380

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension...

The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP versus placebo on exercise capacity in adults with PH-ILD.

Sponsor: Insmed IncorporatedEnrolling: 34420 locations
RECRUITINGNCT01730092

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

Background: \- High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a rare disorder. Some people have disease-associated PAH and some have PAH...

Sponsor: National Institutes of Health Clinical Center (CC)Enrolling: 2701 location
RECRUITINGNCT07149935

Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients

This multicenter, open label, double-arm study aims at investigating the the continuous effect of long-Term rehabilitation training on clinical improvement(ITTCI) and...

Sponsor: RenJi HospitalEnrolling: 1041 location
RECRUITINGNCT05638269

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

The human gut microbiome has been associated with many health factors but variability between studies limits the exploration of effects between them. This study aims to...

Sponsor: Zhujiang HospitalEnrolling: 1200020 locations
RECRUITINGNCT07261956

Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia

This research aims to evaluate the usefulness of lung ultrasound (LUS) for detecting and monitoring fluid overload in patients with severe preeclampsia. Severe preeclampsia is a...

Sponsor: Saint Thomas Hospital, PanamaEnrolling: 2021 location
RECRUITINGPhase 3NCT07218029

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow. This causes high blood...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 81520 locations
RECRUITINGPhase 4NCT07140484

Sotatercept in Pulmonary Arterial Hypertension

The goal of this clinical trial is to determine whether sotatercept is effective in improving diffusing capacity in patients with pulmonary arterial hypertension. Participants...

Sponsor: University of AlbertaEnrolling: 271 location
RECRUITINGNCT06852924

Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE)

High Altitude Pulmonary Edema (HAPE) is a critical, non-cardiogenic pulmonary edema that manifests in high-altitude conditions, marked by the rapid onset of symptoms such as...

Sponsor: Novlead Inc.Enrolling: 1001 location
RECRUITINGNCT00710177

PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn

The purpose of this study is to determine if normally occurring variations in a specific gene called PTGS-1 are associated with an increased risk of narrowing of the ductus...

Sponsor: Medical College of WisconsinEnrolling: 2001 location
RECRUITINGNCT05968859

A Study of Pulmonary Hypertension Peripheral Limitations

The investigators are doing this research study to compare whole body aerobic training with isolated leg training (with weights) and its impact on effectiveness in symptoms and...

Sponsor: Mayo ClinicEnrolling: 451 location
RECRUITINGNCT01884051

Hormonal, Metabolic, and Signaling Interactions in PAH

Our hypothesis is that optimal treatment of the dysfunctional metabolic pathways which underlie PAH will improve pulmonary vascular function and consequences of the disease.

Sponsor: Vanderbilt University Medical CenterEnrolling: 18991 location
RECRUITINGPhase 2NCT07175038

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With...

This study evaluates the effect of ROC-101 in adults with either Pulmonary Arterial Hypertension (PAH) or Pulmonary Hypertension Associated with Interstitial Lung Disease...

Sponsor: AllRock Bio, Inc.Enrolling: 4013 locations
RECRUITINGNCT07180368

Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients

The purpose of this observational study is to understand the impact of polypharmacy on the prognosis of elderly patients with chronic diseases. The main research question it aims...

Sponsor: Xijing HospitalEnrolling: 20001 location
RECRUITINGPhase 2NCT06846554

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

The AP13CP02 study is a phase 2, open-label, dose escalation trial to determine how safe and tolerable multiple subcutaneous (SC) injections of APL-9796 are for patients with PH....

Sponsor: Apollo Therapeutics LtdEnrolling: 485 locations
RECRUITINGPhase 2NCT07221513

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

This is a Phase 2a, open-label, multiple-dose study to assess the safety, tolerability, and efficacy of JK07 in participants 18 to 85 years of age with diagnosed HF and cpcPH. At...

Sponsor: Salubris Biotherapeutics IncEnrolling: 301 location
RECRUITINGNCT07311135

Accuracy of Smartwatches in Measuring Oxygen Levels in Patients With Pulmonary Hypertension: A Pilot Study

The goal of this study is to learn how accurate smartwatches are at measuring oxygen levels in patients with a condition called pulmonary hypertension. The main questions it aims...

Sponsor: Golden Jubilee National HospitalEnrolling: 201 location
RECRUITINGNCT05873387

Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope

The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate...

Sponsor: Eko Devices, Inc.Enrolling: 24203 locations
RECRUITINGNCT06775028

Integrated Approach in Frail Older People with Atrial Fibrillation

The study will verify if a structured multidisciplinary approach (called iABC), aimed to improve the appropriate management of elderly AF patients with multimorbidity (the i-ABC...

Sponsor: Heart Care FoundationEnrolling: 125020 locations
RECRUITINGPhase 2NCT06475781

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD

The goal of this clinical trial is to see if mirivadelgat will work in patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD). It will also learn...

Sponsor: Foresee Pharmaceuticals Co., Ltd.Enrolling: 1269 locations
RECRUITINGNCT06753981

Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world,...

This study is a multicenter, prospective, observational study aimed at investigating the efficacy and safety of triple targeted drug therapy in patients with arterial pulmonary...

Sponsor: Qianfoshan HospitalEnrolling: 481 location
RECRUITINGPhase 4NCT07356778

A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial...

What is this study about? This study will test whether adding sotatercept to usual medicines for pulmonary arterial hypertension (PAH) can help adults who have PAH due to...

Sponsor: Kazuya HosokawaEnrolling: 3610 locations
RECRUITINGNCT06099015

Cera™ Vascular Plug System Post-Market Clinical Follow-Up

The objective of the study is to collect and evaluate clinical data on patients of the Lifetech Cera™ Vascular Plug System to: * confirm the performance * confirm the safety *...

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.Enrolling: 1324 locations
RECRUITINGNCT03169010

Registration Study for Rare Type of Pulmonary Hypertension

The knowledge on the rare type of pulmonary hypertension which can not be explained by left heart disease, respiratory disease or congenital heart disease is very limited....

Sponsor: China National Center for Cardiovascular DiseasesEnrolling: 20001 location
RECRUITINGNCT06917196

PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND...

The PROMPTLY study is a proof-of-concept research project evaluating the efficacy of XHALIP, an innovative inhalable formulation of Imatinib, in treating pulmonary arterial...

Sponsor: Fondazione IRCCS Policlinico San Matteo di PaviaEnrolling: 161 location
RECRUITINGNCT06386185

Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography

The goal of this observational study is to assess the efficacy that the addition of novel markers cardiac function, particularly of right ventricular (RV) function in...

Sponsor: Royal United Hospitals Bath NHS Foundation TrustEnrolling: 25005 locations
RECRUITINGPhase 3NCT05983250

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

This study will evaluate the efficacy of TNX-103 (oral levosimendan) compared with placebo in subjects with PH-HFpEF as measured by the change in 6-Minute Walk Distance (6 MWD;...

Sponsor: Tenax Therapeutics, Inc.Enrolling: 23020 locations
RECRUITINGNCT06374277

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge....

Sponsor: University of TennesseeEnrolling: 3882 locations
RECRUITINGEarly Phase 1NCT05452889

PET Image in PAH Patients

Pulmonary arterial hypertension (PAH) is mortal disease affecting the blood vessels of the lung. Despite its morbid prognosis, PAH is often misdiagnosed or ignored, with an...

Sponsor: Stephen Y. ChanEnrolling: 711 location
RECRUITINGNCT05719415

Functional Pulmonary Capillary Surface Area in BPA for CTEPH

Chronic thromboembolic pulmonary hypertension \[CTEPH\] is caused by pulmonary emboli that have enlarged in pulmonary arteries and have become organized into the vessel wall. Many...

Sponsor: Jewish General HospitalEnrolling: 401 location
RECRUITINGPhase 2 / Phase 3NCT07462260

Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)

Pulmonary hypertension secondary to left heart disease is associated with increased morbidity and mortality, particularly in patients with rheumatic chronic valvular heart...

Sponsor: Sindh Institute of Cardiovascular DiseasesEnrolling: 1001 location
RECRUITINGNCT06081881

Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism

to detect the incidence of CTEPH patients. Primary outcome To predict CETHP in symptomatic patients after pulmonary embolism episode. Secondary outcome: On Echocardiography...

Sponsor: Ester Ashraf Faried BeshayEnrolling: 1001 location
RECRUITINGPhase 1 / Phase 2NCT04898114

Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn

The aim of this study is to evaluate the effectiveness of nebulized magnesium sulfate combined with sildenafil citrate, compared with sildenafil citrate alone, in treating...

Sponsor: Sohag UniversityEnrolling: 401 location
RECRUITINGPhase 1 / Phase 2NCT06777316

A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

This is an open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetic (what the body does to the drug), pharmacodynamic (what the drug does to the body), and...

Sponsor: Cogent Biosciences, Inc.Enrolling: 11015 locations
RECRUITINGNCT07161908

Controlled Remote Monitoring and Optimization of Oxygen Therapy in Preterm Infants

The project is a national, prospective, multicenter, interventional pilot project focused on controlled remote monitoring and optimization of oxygen therapy for premature infants...

Sponsor: Institute of Health Information and Statistics of the Czech RepublicEnrolling: 704 locations
RECRUITINGPhase 2NCT06053580

Repurposing Valsartan May Protect Against Pulmonary Hypertension

This is a Phase 2, single-center, randomized placebo controlled trial of valsartan (an angiotensin receptor blocker) in adults with pulmonary arterial hypertension. The study will...

Sponsor: University of WashingtonEnrolling: 601 location
RECRUITINGNCT06671171

Wearable Assessment of Thoracic, Cardiac Health and Exercise Performance Trial

Wearable health technology, particularly smartwatches, has revolutionized personal health monitoring by enabling continuous, non-invasive tracking of various physiological...

Sponsor: The University of Hong KongEnrolling: 501 location
RECRUITINGNCT04278404

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of...

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults...

Sponsor: Duke UniversityEnrolling: 500020 locations
RECRUITINGPhase 2NCT07333183

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

This is a Phase 2, open-label, multi-center clinical study to evaluate the safety and efficacy of inhaled mosliciguat in participants with pulmonary hypertension associated with...

Sponsor: Pulmovant, Inc.Enrolling: 201 location
RECRUITINGNCT02986087

Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia

Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses.

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 401 location
RECRUITINGNCT06299436

Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure

Right ventricular (RV) failure is recognized to worsen patient outcomes in the setting of heart failure with reduced ejection fraction (HFrEF)-related pulmonary hypertension (PH),...

Sponsor: Johns Hopkins UniversityEnrolling: 501 location
RECRUITINGPhase 4NCT04484675

Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension

The investigator compared difference between inhaled and intravenous milirinone in patiens with severe pulmonary hypertension undergoing cardiac surgery

Sponsor: Zagazig UniversityEnrolling: 381 location
RECRUITINGNCT04993612

Postcapillary Blood Gas Analysis in Wedge Position (Wedge-BGA)

If pulmonary hypertension is suspected, a right heart catheterization is usually performed to confirm or rule out the diagnosis. As part of this examination, blood samples are...

Sponsor: Ayham DaherEnrolling: 1001 location
RECRUITINGPhase 1NCT06429930

Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults

This is the second single ascending dose study of L608 in healthy participants and is being conducted to evaluate the safety of L608 with dose level ranging from 15 μg to 30 μg.

Sponsor: Pharmosa Biopharm Inc.Enrolling: 321 location

Showing 50 of 102 trials.Search all Pulmonary Hypertension trials